Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study
Purpose Rezūm is the latest developed minimally invasive treatment for benign prostatic hyperplasia (BPH). We aimed to carefully assess the functional outcomes of patients treated with Rezūm for BPH. Methods We prospectively followed 135 consecutive patients treated by Rezūm at 5 institutions from J...
Gespeichert in:
| Veröffentlicht in: | World journal of urology 2021-10, Vol.39 (10), p.3875-3880 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3880 |
|---|---|
| container_issue | 10 |
| container_start_page | 3875 |
| container_title | World journal of urology |
| container_volume | 39 |
| creator | Siena, Giampaolo Cindolo, L. Ferrari, G. Maruzzi, D. Fasolis, G. Condorelli, S. V. Varvello, F. Visalli, F. Rabito, S. Toso, S. Caroassai, S. Mari, A. Viola, L. Somani, B. K. Carini, M. |
| description | Purpose
Rezūm is the latest developed minimally invasive treatment for benign prostatic hyperplasia (BPH). We aimed to carefully assess the functional outcomes of patients treated with Rezūm for BPH.
Methods
We prospectively followed 135 consecutive patients treated by Rezūm at 5 institutions from June 2019 to August 2020. The International Prostate Symptom Score (IPSS), International Consultation on Incontinence Questionnaire-Short Form (ICIQ-UI SF), the Overactive Bladder Questionnaire-Short Form (OAB-q SF) score, the International Index of Erectile Function (IIEF-5) and questions 9 and 10 to assess ejaculatory dysfunction were recorded.
Election criteria were age > 18, no prior prostate interventions, IPSS ≥ 13, post-void residual ≤ 250 mL, prostate volume between 30 and 120 cc.
Results
The median operative time was 10.5 (IQR 8.7–15) min. All patients were dismissed few hours after surgery with indwelling urinary catheter that was removed after a median of 7 (IQR 7–10) days. A significantly decrease of IPSS from baseline at first (
p
= 0.001) and third (
p
|
| doi_str_mv | 10.1007/s00345-021-03642-4 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8010783</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2582274597</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-b9e1ab2cff326b543e5918e48aeb8b4105a1a32bd0a77b4d03591f7a0b79886f3</originalsourceid><addsrcrecordid>eNp9kUtu1TAUhi0EoreFDTBAlpi0g4BfiR0GSKjiUakSEgIxtI4T515XThxspygshg2wDvaF21vKY8DIks_3_-fxI_SIkqeUEPksEcJFXRFGK8IbwSpxB22o4LxSkjV30YZIJirRKn6ADlO6IITKhtT30QHnUslWNRv07RNkG_ElzCHivLMR5hUfv7dff3wfT_BQPn34UoAlugniinOELuO0jnMOY8LR-qLvcQ7Y2MltJzzHkDJk1-HdOts4e0gOnmML0a8FT4vPCQ8xjFfd8OBiyvgsg3cw4bEUXWenHIs85aVfH6B7A_hkH968R-jj61cfTt9W5-_enJ2-PK86IUWuTGspGNYNA2eNqQW3dUuVFQqsUUZQUgMFzkxPQEojesJLfZBATLmCagZ-hF7sfefFjLa_ngG8nqMby9Y6gNN_Vya309twqRWhRCpeDI5vDGL4vNiU9ehSZ72HyYYlaVYTWdKoKSnok3_Qi7DEqaxXKMWYFHUrC8X2VFcOmqIdboehRF_Fr_fx6xK_vo5fiyJ6_Ocat5JfeReA74FUStPWxt-9_2P7Ey-cwI0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2582274597</pqid></control><display><type>article</type><title>Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Siena, Giampaolo ; Cindolo, L. ; Ferrari, G. ; Maruzzi, D. ; Fasolis, G. ; Condorelli, S. V. ; Varvello, F. ; Visalli, F. ; Rabito, S. ; Toso, S. ; Caroassai, S. ; Mari, A. ; Viola, L. ; Somani, B. K. ; Carini, M.</creator><creatorcontrib>Siena, Giampaolo ; Cindolo, L. ; Ferrari, G. ; Maruzzi, D. ; Fasolis, G. ; Condorelli, S. V. ; Varvello, F. ; Visalli, F. ; Rabito, S. ; Toso, S. ; Caroassai, S. ; Mari, A. ; Viola, L. ; Somani, B. K. ; Carini, M.</creatorcontrib><description>Purpose
Rezūm is the latest developed minimally invasive treatment for benign prostatic hyperplasia (BPH). We aimed to carefully assess the functional outcomes of patients treated with Rezūm for BPH.
Methods
We prospectively followed 135 consecutive patients treated by Rezūm at 5 institutions from June 2019 to August 2020. The International Prostate Symptom Score (IPSS), International Consultation on Incontinence Questionnaire-Short Form (ICIQ-UI SF), the Overactive Bladder Questionnaire-Short Form (OAB-q SF) score, the International Index of Erectile Function (IIEF-5) and questions 9 and 10 to assess ejaculatory dysfunction were recorded.
Election criteria were age > 18, no prior prostate interventions, IPSS ≥ 13, post-void residual ≤ 250 mL, prostate volume between 30 and 120 cc.
Results
The median operative time was 10.5 (IQR 8.7–15) min. All patients were dismissed few hours after surgery with indwelling urinary catheter that was removed after a median of 7 (IQR 7–10) days. A significantly decrease of IPSS from baseline at first (
p
= 0.001) and third (
p
< 0.0001) month after surgery was reported. No difference was reported in terms of ICIQ-UI SF score postoperatively. A mild reduction of the OAB-q SF score was reported at 1 month from surgery (
p
= 0.06) that turned significant at 3 months postoperatively (
p
< 0.0001). A slight but statistically significant increase of the IIEF-5 score was reported from baseline at 6 months (
p
= 0.04). Postoperatively, patients reported a significantly decrease of ejaculatory dysfunction after alpha-blocker interruption.
Conclusion
Rezūm treatment is a feasible minimally invasive option for patients with BPH symptoms and showed optimal early functional outcomes.</description><identifier>ISSN: 0724-4983</identifier><identifier>EISSN: 1433-8726</identifier><identifier>DOI: 10.1007/s00345-021-03642-4</identifier><identifier>PMID: 33787986</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aged ; Catheters ; Follow-Up Studies ; Genital diseases ; Humans ; Hyperplasia ; Hyperthermia, Induced - instrumentation ; Italy ; Lower Urinary Tract Symptoms - etiology ; Lower Urinary Tract Symptoms - therapy ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Nephrology ; Oncology ; Original ; Original Article ; Patients ; Prospective Studies ; Prostate ; Prostatic Hyperplasia - complications ; Questionnaires ; Recovery of Function ; Statistical analysis ; Steam ; Surgery ; Surveys and Questionnaires ; Treatment Outcome ; Urinary tract ; Urology ; Water vapor</subject><ispartof>World journal of urology, 2021-10, Vol.39 (10), p.3875-3880</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-b9e1ab2cff326b543e5918e48aeb8b4105a1a32bd0a77b4d03591f7a0b79886f3</citedby><cites>FETCH-LOGICAL-c474t-b9e1ab2cff326b543e5918e48aeb8b4105a1a32bd0a77b4d03591f7a0b79886f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00345-021-03642-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00345-021-03642-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33787986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Siena, Giampaolo</creatorcontrib><creatorcontrib>Cindolo, L.</creatorcontrib><creatorcontrib>Ferrari, G.</creatorcontrib><creatorcontrib>Maruzzi, D.</creatorcontrib><creatorcontrib>Fasolis, G.</creatorcontrib><creatorcontrib>Condorelli, S. V.</creatorcontrib><creatorcontrib>Varvello, F.</creatorcontrib><creatorcontrib>Visalli, F.</creatorcontrib><creatorcontrib>Rabito, S.</creatorcontrib><creatorcontrib>Toso, S.</creatorcontrib><creatorcontrib>Caroassai, S.</creatorcontrib><creatorcontrib>Mari, A.</creatorcontrib><creatorcontrib>Viola, L.</creatorcontrib><creatorcontrib>Somani, B. K.</creatorcontrib><creatorcontrib>Carini, M.</creatorcontrib><title>Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study</title><title>World journal of urology</title><addtitle>World J Urol</addtitle><addtitle>World J Urol</addtitle><description>Purpose
Rezūm is the latest developed minimally invasive treatment for benign prostatic hyperplasia (BPH). We aimed to carefully assess the functional outcomes of patients treated with Rezūm for BPH.
Methods
We prospectively followed 135 consecutive patients treated by Rezūm at 5 institutions from June 2019 to August 2020. The International Prostate Symptom Score (IPSS), International Consultation on Incontinence Questionnaire-Short Form (ICIQ-UI SF), the Overactive Bladder Questionnaire-Short Form (OAB-q SF) score, the International Index of Erectile Function (IIEF-5) and questions 9 and 10 to assess ejaculatory dysfunction were recorded.
Election criteria were age > 18, no prior prostate interventions, IPSS ≥ 13, post-void residual ≤ 250 mL, prostate volume between 30 and 120 cc.
Results
The median operative time was 10.5 (IQR 8.7–15) min. All patients were dismissed few hours after surgery with indwelling urinary catheter that was removed after a median of 7 (IQR 7–10) days. A significantly decrease of IPSS from baseline at first (
p
= 0.001) and third (
p
< 0.0001) month after surgery was reported. No difference was reported in terms of ICIQ-UI SF score postoperatively. A mild reduction of the OAB-q SF score was reported at 1 month from surgery (
p
= 0.06) that turned significant at 3 months postoperatively (
p
< 0.0001). A slight but statistically significant increase of the IIEF-5 score was reported from baseline at 6 months (
p
= 0.04). Postoperatively, patients reported a significantly decrease of ejaculatory dysfunction after alpha-blocker interruption.
Conclusion
Rezūm treatment is a feasible minimally invasive option for patients with BPH symptoms and showed optimal early functional outcomes.</description><subject>Aged</subject><subject>Catheters</subject><subject>Follow-Up Studies</subject><subject>Genital diseases</subject><subject>Humans</subject><subject>Hyperplasia</subject><subject>Hyperthermia, Induced - instrumentation</subject><subject>Italy</subject><subject>Lower Urinary Tract Symptoms - etiology</subject><subject>Lower Urinary Tract Symptoms - therapy</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Nephrology</subject><subject>Oncology</subject><subject>Original</subject><subject>Original Article</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Prostate</subject><subject>Prostatic Hyperplasia - complications</subject><subject>Questionnaires</subject><subject>Recovery of Function</subject><subject>Statistical analysis</subject><subject>Steam</subject><subject>Surgery</subject><subject>Surveys and Questionnaires</subject><subject>Treatment Outcome</subject><subject>Urinary tract</subject><subject>Urology</subject><subject>Water vapor</subject><issn>0724-4983</issn><issn>1433-8726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtu1TAUhi0EoreFDTBAlpi0g4BfiR0GSKjiUakSEgIxtI4T515XThxspygshg2wDvaF21vKY8DIks_3_-fxI_SIkqeUEPksEcJFXRFGK8IbwSpxB22o4LxSkjV30YZIJirRKn6ADlO6IITKhtT30QHnUslWNRv07RNkG_ElzCHivLMR5hUfv7dff3wfT_BQPn34UoAlugniinOELuO0jnMOY8LR-qLvcQ7Y2MltJzzHkDJk1-HdOts4e0gOnmML0a8FT4vPCQ8xjFfd8OBiyvgsg3cw4bEUXWenHIs85aVfH6B7A_hkH968R-jj61cfTt9W5-_enJ2-PK86IUWuTGspGNYNA2eNqQW3dUuVFQqsUUZQUgMFzkxPQEojesJLfZBATLmCagZ-hF7sfefFjLa_ngG8nqMby9Y6gNN_Vya309twqRWhRCpeDI5vDGL4vNiU9ehSZ72HyYYlaVYTWdKoKSnok3_Qi7DEqaxXKMWYFHUrC8X2VFcOmqIdboehRF_Fr_fx6xK_vo5fiyJ6_Ocat5JfeReA74FUStPWxt-9_2P7Ey-cwI0</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Siena, Giampaolo</creator><creator>Cindolo, L.</creator><creator>Ferrari, G.</creator><creator>Maruzzi, D.</creator><creator>Fasolis, G.</creator><creator>Condorelli, S. V.</creator><creator>Varvello, F.</creator><creator>Visalli, F.</creator><creator>Rabito, S.</creator><creator>Toso, S.</creator><creator>Caroassai, S.</creator><creator>Mari, A.</creator><creator>Viola, L.</creator><creator>Somani, B. K.</creator><creator>Carini, M.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211001</creationdate><title>Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study</title><author>Siena, Giampaolo ; Cindolo, L. ; Ferrari, G. ; Maruzzi, D. ; Fasolis, G. ; Condorelli, S. V. ; Varvello, F. ; Visalli, F. ; Rabito, S. ; Toso, S. ; Caroassai, S. ; Mari, A. ; Viola, L. ; Somani, B. K. ; Carini, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-b9e1ab2cff326b543e5918e48aeb8b4105a1a32bd0a77b4d03591f7a0b79886f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Catheters</topic><topic>Follow-Up Studies</topic><topic>Genital diseases</topic><topic>Humans</topic><topic>Hyperplasia</topic><topic>Hyperthermia, Induced - instrumentation</topic><topic>Italy</topic><topic>Lower Urinary Tract Symptoms - etiology</topic><topic>Lower Urinary Tract Symptoms - therapy</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Nephrology</topic><topic>Oncology</topic><topic>Original</topic><topic>Original Article</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Prostate</topic><topic>Prostatic Hyperplasia - complications</topic><topic>Questionnaires</topic><topic>Recovery of Function</topic><topic>Statistical analysis</topic><topic>Steam</topic><topic>Surgery</topic><topic>Surveys and Questionnaires</topic><topic>Treatment Outcome</topic><topic>Urinary tract</topic><topic>Urology</topic><topic>Water vapor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Siena, Giampaolo</creatorcontrib><creatorcontrib>Cindolo, L.</creatorcontrib><creatorcontrib>Ferrari, G.</creatorcontrib><creatorcontrib>Maruzzi, D.</creatorcontrib><creatorcontrib>Fasolis, G.</creatorcontrib><creatorcontrib>Condorelli, S. V.</creatorcontrib><creatorcontrib>Varvello, F.</creatorcontrib><creatorcontrib>Visalli, F.</creatorcontrib><creatorcontrib>Rabito, S.</creatorcontrib><creatorcontrib>Toso, S.</creatorcontrib><creatorcontrib>Caroassai, S.</creatorcontrib><creatorcontrib>Mari, A.</creatorcontrib><creatorcontrib>Viola, L.</creatorcontrib><creatorcontrib>Somani, B. K.</creatorcontrib><creatorcontrib>Carini, M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Siena, Giampaolo</au><au>Cindolo, L.</au><au>Ferrari, G.</au><au>Maruzzi, D.</au><au>Fasolis, G.</au><au>Condorelli, S. V.</au><au>Varvello, F.</au><au>Visalli, F.</au><au>Rabito, S.</au><au>Toso, S.</au><au>Caroassai, S.</au><au>Mari, A.</au><au>Viola, L.</au><au>Somani, B. K.</au><au>Carini, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study</atitle><jtitle>World journal of urology</jtitle><stitle>World J Urol</stitle><addtitle>World J Urol</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>39</volume><issue>10</issue><spage>3875</spage><epage>3880</epage><pages>3875-3880</pages><issn>0724-4983</issn><eissn>1433-8726</eissn><abstract>Purpose
Rezūm is the latest developed minimally invasive treatment for benign prostatic hyperplasia (BPH). We aimed to carefully assess the functional outcomes of patients treated with Rezūm for BPH.
Methods
We prospectively followed 135 consecutive patients treated by Rezūm at 5 institutions from June 2019 to August 2020. The International Prostate Symptom Score (IPSS), International Consultation on Incontinence Questionnaire-Short Form (ICIQ-UI SF), the Overactive Bladder Questionnaire-Short Form (OAB-q SF) score, the International Index of Erectile Function (IIEF-5) and questions 9 and 10 to assess ejaculatory dysfunction were recorded.
Election criteria were age > 18, no prior prostate interventions, IPSS ≥ 13, post-void residual ≤ 250 mL, prostate volume between 30 and 120 cc.
Results
The median operative time was 10.5 (IQR 8.7–15) min. All patients were dismissed few hours after surgery with indwelling urinary catheter that was removed after a median of 7 (IQR 7–10) days. A significantly decrease of IPSS from baseline at first (
p
= 0.001) and third (
p
< 0.0001) month after surgery was reported. No difference was reported in terms of ICIQ-UI SF score postoperatively. A mild reduction of the OAB-q SF score was reported at 1 month from surgery (
p
= 0.06) that turned significant at 3 months postoperatively (
p
< 0.0001). A slight but statistically significant increase of the IIEF-5 score was reported from baseline at 6 months (
p
= 0.04). Postoperatively, patients reported a significantly decrease of ejaculatory dysfunction after alpha-blocker interruption.
Conclusion
Rezūm treatment is a feasible minimally invasive option for patients with BPH symptoms and showed optimal early functional outcomes.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33787986</pmid><doi>10.1007/s00345-021-03642-4</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0724-4983 |
| ispartof | World journal of urology, 2021-10, Vol.39 (10), p.3875-3880 |
| issn | 0724-4983 1433-8726 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8010783 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Aged Catheters Follow-Up Studies Genital diseases Humans Hyperplasia Hyperthermia, Induced - instrumentation Italy Lower Urinary Tract Symptoms - etiology Lower Urinary Tract Symptoms - therapy Male Medicine Medicine & Public Health Middle Aged Nephrology Oncology Original Original Article Patients Prospective Studies Prostate Prostatic Hyperplasia - complications Questionnaires Recovery of Function Statistical analysis Steam Surgery Surveys and Questionnaires Treatment Outcome Urinary tract Urology Water vapor |
| title | Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T02%3A58%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Water%20vapor%20therapy%20(Rez%C5%ABm)%20for%20lower%20urinary%20tract%20symptoms%20related%20to%20benign%20prostatic%20hyperplasia:%20early%20results%20from%20the%20first%20Italian%20multicentric%20study&rft.jtitle=World%20journal%20of%20urology&rft.au=Siena,%20Giampaolo&rft.date=2021-10-01&rft.volume=39&rft.issue=10&rft.spage=3875&rft.epage=3880&rft.pages=3875-3880&rft.issn=0724-4983&rft.eissn=1433-8726&rft_id=info:doi/10.1007/s00345-021-03642-4&rft_dat=%3Cproquest_pubme%3E2582274597%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2582274597&rft_id=info:pmid/33787986&rfr_iscdi=true |